August 8, 2022

Volume XII, Number 220

Advertisement
Advertisement

August 05, 2022

Subscribe to Latest Legal News and Analysis

Intellectual Property, Patent, Trademark and Copyright Law News

Intellectual property applies to many different areas of the legal world. Applying for patents for work-products, by individual employees, trademark laws, copyrights, and how companies leverage their IP asset-rights over employees, are just a few of the many areas the National Law Review covers as it pertains to IP.

Intellectual Property Litigation

Intellectual Property disputes are a complex area of law, often involving deep dives into complex concepts to understand the issues at play. In the United States, the United States Patent and Trademark Office (USPTO/PTO) is the agency involved in registering patents and trademarks.   As part of the USPTO, the Patent Trial and Appeal Board settles patent disputes, using a variety of mechanisms to settle issues related to intellectual property.    Some of the mechanisms include inter partes review, post-grant procedures, and covered business method patent reviews.  Issues related to the America Invents Act are also settled through the PTAB. The National Law Review covers changes to standards held by the USPTO in litigation and other patent issues.  The Trademark Trial and Appeal Board settles disputes related to trademarks, such as an ex parte appeal from the denial of an application for registration by an examining attorney, and an inter partes opposition, cancellation, concurrent use, or interference proceeding.  Other agencies involved in patent disputes are the International Trade Commission (ITC) or the Federal Trade Commission (FTC).  The National Law Review covers patent news as it relates to Supreme Court (SCOTUS) and federal circuit courts’ appeals, as well as general patent litigation and new patent filings.

Intellectual Property in Drug Patents

Legal analysis related to drug patents and pharmaceuticals and the interplay with intellectual property issues are also covered by the National Law Review.   Drug patents, biosimilars, generic top-level domain registration (gTLD), trade secrets, non-compete clauses, and other patent application news are updated on the site regularly. Additionally, tangential issues that impact pharmaceutical companies, such as innovator liability and related litigation, are also analyzed by the legal experts who write for the National Law Review. 

Intellectual Property in an Employment Context

The National Law Review has legal analysis on the intersection between intellectual property rights and employment, and who owns ideas, the Work Made For Hire principle as well resulting litigation. Additionally, legislation such as the Defense of Trade Secrets Act and its impact on workplaces, and ongoing litigation related to the legislation is also covered.

International Intellectual Property

Visitors to the site will oftentimes read about international news as it relates to patent applications in the US, and internationally as well. Pharmaceutical patents in Brazil, medical device patent applications from the United Kingdom, or litigation from the European Union, China, India, and other international sectors, are often covered online. Visitors will find the latest coverage, news, and insights on patent applications and litigation, when visiting the National Law Review, for up-to-date practice-area news.

For hourly updates on the latest news about Intellectual Property Law, IP Litigation, Patent Legislation, and more, be sure to follow our IP Law Twitter feed, and sign up for complimentary e-news bulletins.

Date Title Organization
15
Jun
Non-Disparagement Clauses in Employment Contracts Still Valid under New Jersey Law Stark & Stark
14
Jun
The Legit Ledger Episode 1: Intellectual Property Considerations for Licensing NFTs with Yasamin Parsafar and Jim Gatto [PODCAST] Sheppard, Mullin, Richter & Hampton LLP
14
Jun
EUON Announces Update to NanoData Bergeson & Campbell, P.C.
14
Jun
DOJ Breaking with Big Tech Approach to SEPs Mintz
14
Jun
Microsoft to Eliminate Noncompetes for Most Employees – a Harbinger of Things to Come? Epstein Becker & Green, P.C.
14
Jun
A High Mountain to Climb: Filing DTSA Claims Without any Evidence is Not Enough to Meet “Bad Faith” Standard for Awarding Attorneys’ Fees to Opponent Sheppard, Mullin, Richter & Hampton LLP
13
Jun
Withdrawing Trump-Era Policy on Standard Essential Patents, Agencies Favor ‘Case by Case’ Approach MoginRubin
13
Jun
Considerations of Copyright and First Amendment Rights in Appropriation Art Wilson Elser Moskowitz Edelman & Dicker LLP
13
Jun
Ninth Circuit Rules Hemp-Derived Delta-8 THC Products Are Federally Legal, Creating Broad Implications for the Hemp, Marijuana and Insurance Industries Wilson Elser Moskowitz Edelman & Dicker LLP
11
Jun
China Claims Over 18,000 5G Standard Essential Patent Families Ranking First in the World Schwegman, Lundberg & Woessner, P.A.
10
Jun
Ninth Circuit Extends Trademark Protection to Delta-8 THC Goods Norris McLaughlin P.A.
9
Jun
“Well frens, it happened to me;” Actor’s Stolen NFTs Highlight Uncertainties for NFT Artwork Robinson & Cole LLP
9
Jun
Drink Up, but Not with Lehman Brand McDermott Will & Emery
9
Jun
Can’t Hide Behind Minor Clerical Error to Escape Willful Infringement Verdict McDermott Will & Emery
9
Jun
“Self-Similar” More Objective Than One Might Think McDermott Will & Emery
8
Jun
China’s National Intellectual Property Administration Announces Record 2.49 Million RMB Fine Against Patent Firm for Unauthorized Practice of Law and Filing Abnormal Patent Applications Schwegman, Lundberg & Woessner, P.A.
8
Jun
Green Innovation Being Fast Tracked by USPTO Womble Bond Dickinson (US) LLP
8
Jun
China’s Supreme People’s Procuratorate & Ministry of Public Security Jointly Issue Typical Cases Involving Obstructing Epidemic Prevention Including Two Trademark Cases Schwegman, Lundberg & Woessner, P.A.
7
Jun
Indirect Patent Infringement Down Under K&L Gates
6
Jun
China’s National Intellectual Property Administration Issues 2021 Annual Report: Invention Patent Application Filings Reached 1.586 Million! Schwegman, Lundberg & Woessner, P.A.

Pages

Advertisement
Advertisement